PD retweeted
YTD $MSOS summary Q1-Q3 Jan 1-Sept 30/22:
30 inflows = 15,240,000 share creates valued at $270,166,850
19 outflows = (4,165,000) share redeems valued at ($78,803,650)
Net increase to S/O = 11,075,000 = net inflows valued at $191,363,200
S/O start 44,815,000 end 55,890,000
8/9
PD retweeted
The Narrowing of Psychedelic Discourse
If you lived through the #psychedelic #revolution of the 1960s, you will remember a time when psychedelics represented the pinnacle of human potential as proclaimed by #AldousHuxley & #TimothyLeary
by @jameslkent
bit.ly/3fthYvh
PD retweeted
MindMed Announces Positive Results from Collaborators' Placebo-Controlled Investigator-Initiated Trial Published in Peer-Reviewed Journal
$MNMD $MMED
prnewswire.com/news-releases…
Actually some good info in this article, along with what seems like more good news for the sector, and I appreciated the balanced.
To Hallucinate or Not: The Big Questions Facing #Psychedelics at FENS #2022
The tide around #psychedelic science is changing with the decision by the organizers of @ECNPtweets conference to carve out a slot for #psychedelic research
via @Tech_Networks
bit.ly/3xmWXsr
PD retweeted
Yes - You guessed right!
PSYCBiz has changed to PSYC_Spot & is the new home of Psychedelic Spotlight while #Twitter twiddles it's thumbs 😎
$PSYC #TeamPSYC #psychedelics #News #Update #media #lifestyle #culture #psilocybin
PD retweeted
Another week where the psychedelic industry shows price action resilience among biopharma stocks. @ARKInvest released a much-anticipated and thorough research report that turned heads. And the sector's news flow king, $CYBN, kept it up.
thedalesreport.com/psychedel…
It's a shame what this legitimate company posting original content has had to go through.
This quoted post is unavailable.
PD retweeted
.@CybinInc makes positive progress towards its goal of advancing #psychedelics to #therapeutics
@insidepharma: "Going from the bench to the clinic in 18 months is pretty fantastic"
$CYBN has moved from the lab to the clinic w/ programs underway
bit.ly/3wPd4hU #stocks
PD retweeted
The Price history screens have finally updated so I am following up with the inflow details as promised. $PSIL had 275,000 share creates yesterday valued at $1,028,500 so my $1M guess was pretty close! 😁 Have a great day!
PD retweeted
As we move deeper into the #Psychedelic Renaissance, many different options are proposed
Psychedelic #decriminalization, medicalization & #legalization are all suggested pathways that each carry their own benefits
So what’s the difference?
bit.ly/3TuXr93
#psychedelics
PD retweeted
.@MindsetPharma Further Expands its #IP Portfolio with Three Additional Non-Tryptamine Families of Next-Generation #Psychedelic Compounds
$MSET has purposefully expanded its discovery efforts beyond the #tryptamine drug class into new chemical structures
bit.ly/3KNN7W1
I was about to share this, then I thought, wait, I'll get @junglejava1 has already shared this. JJ is on it.
"The Company will conduct a conference call and webcast to discuss its results the following morning, Tuesday, August 30, 2022 at 8:30 a.m. ET."
Field Trip Health & Wellness Ltd. Reports Fiscal First Quarter 2023 Financial and Operating Results
$FTHW
globenewswire.com/news-relea…
PD retweeted
Season Finale of Spotlight in Focus
In this segment @PSYCCEO talks to @TheSporeGroup’s Mia Lowry, @SoundMind_Inst’s Taylor Flatt, @BalancedNetwork’s Ron Millward, & Colette Condorcita of Decriminalize Nature #Philidelphia
bit.ly/3pLPX46
$PSYC #TeamPSYC #psychedelic
PD retweeted
#BreakingNews for $SPRC - @SciSparc Ltd. Announces Additional Positive Results for the Cocaine Addiction Treatment of its #Psychedelic-based Pharma Collaboration with @ClearmindCMND finance.yahoo.com/news/scisp…
#stocks #stocksinfocus #stockstobuy
PD retweeted
Season Finale of Spotlight in Focus: We visit a #psychedelics festival, learn about the #Microdosing Collective & visit a #ketamine clinic run by @fieldtriphealth
You don't want to miss this!
bit.ly/3pNXCPr
#psychedelic #drugs #psilocybin #microdose #shrooms $FTHW
PD retweeted
PharmaDrug Successfully Completes Key Milestone to Support cGMP Production of Clinical Lead Candidate PD-001 Its Patented Orally Available Version of #Cepharanthine for Oncology & Infectious Disease
bit.ly/3wbkqft
$PHRX $LMLLF | #cancer #esophageal #prostate #COVID19
A real shame, a stain on the space, and some good money (of mine) flushed down the toilet.
Mydecine Looks Set to Cease Operations
Many saw this coming, with a series of bearish signals throught 2022.
Here's a very brief timeline of our reporting on $MYCO:












